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bTATE-OF-THE-ART PAPER1895Options for STEMI Patients Ineligible for Reperfusion Therapyarc Cohen, Catalin Boiangiu, Mateen Abidi
ohen and colleagues review the data which demonstrate that a significant proportion of
T-segment elevation myocardial infarction (STEMI) patients are not offered any reperfusion
herapy. Spontaneous reperfusion and contraindications to the use of fibrinolytics and/or
echanical reperfusion account for only a small proportion of these clinical situations. The
ecent data which challenge the boundary between “timely” and “late” presentation in
TEMI, and the impact of sex and age on the eligibility and/or choice of reperfusion therapy
re reviewed. The published evidence and clinical guidelines for various scenarios and
nterventions are summarized.CLINICAL RESEARCH LINICAL TRIALS1907rhNRG-1 Infusion May Augment Reverse Remodelingunlin Gao, Jian Zhang, Liuquan Cheng, Xuesi Wu, Wei Dong, Xinchun Yang, Tianchang Li, Xifu Liu,
abei Xu, Xinyan Li, Mingdong Zhou
ecombinant human neuregulin (rhNRG)-1 has proven effective in animal models of
ongestive heart failure (CHF), but this is the first placebo-controlled trial in human subjects.
total of 44 subjects with New York Heart Association functional class II or III CHF and
n ejection fraction 40% were randomized to either placebo or rhNRG-1 infusion in
ddition to standard CHF therapies. Although not statistically different from placebo, the
jection fraction was significantly increased by 27% at day 30 in the 0.6-g/kg group, while it
as only increased by 5.8% in the placebo group. There were also decreases in end-systolic
nd -diastolic volumes at day 30, and both volumes decreased further at day 90. This trial
ay have been underpowered to detect significant differences from standard CHF therapy,
ut rhNRG-1 appears promising for stimulating reverse remodeling.(continued on page A-20)
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ELINICAL TRIALS1915Addition of Inhaled Treprostinil to Oral Therapy for PAHallerie V. McLaughlin, Raymond L. Benza, Lewis J. Rubin, Richard N. Channick, Robert Voswinckel,
ictor F. Tapson, Ivan M. Robbins, Horst Olschewski, Melvyn Rubenfire, Werner Seeger
his study by McLaughlin and colleagues assessed the efficacy and safety of inhaled
reprostinil in pulmonary arterial hypertension (PAH) patients receiving therapy with either
osentan or sildenafil. PAH patients with a 6-min walk distance (6MWD) of 200 to 450 m
hile treated with bosentan or sildenafil were randomized to inhaled treprostinil or placebo.
he placebo-corrected median change from baseline in peak 6MWD was 19 m at week 6
nd 20 m at week 12. Inhaled treprostinil was safe, well-tolerated, and appears to be effective
s add-on therapy to either bosentan or sildenafil.NTERVENTIONAL CARDIOLOGY1923Calculating the Risk of Death in Patients Undergoing PCIric D. Peterson, David Dai, Elizabeth R. DeLong, J. Matthew Brennan, Mandeep Singh,
unil V. Rao, Richard E. Shaw, Matthew T. Roe, Kalon K. L. Ho, Lloyd W. Klein, Ronald J. Krone,
illiam S. Weintraub, Ralph G. Brindis, John S. Rumsfeld, John A. Spertus, on behalf of
he NCDR Registry Participants
eterson and colleagues sought to create contemporary models for predicting mortality risk
ollowing percutaneous coronary intervention (PCI) by using data from almost 200,000
atients. Overall, PCI in-hospital mortality ranged from 0.65% in elective PCI to 4.81% in
T-segment elevation myocardial infarction (STEMI) patients. Multiple pre-procedural
linical factors were significantly associated with in-hospital mortality. Angiographic variables
rovided only modest incremental information. The overall NCDR model, as well as a
implified NCDR risk score (based on 8 pre-procedure factors), had excellent discrimination.
his model can accurately quantify procedural risks to facilitate comparative effectiveness
esearch, provider comparisons, and informed decision making.ditorial Comment: Dean J. Kereiakes, p. 1933NTERVENTIONAL CARDIOLOGY1936IVUS Findings in Patients With Very Late Stent Thrombosisheol Whan Lee, Su-Jin Kang, Duk-Woo Park, Seung-Hwan Lee, Young-Hak Kim, Jae-Joong Kim,
eong-Wook Park, Gary S. Mintz, Seung-Jung Park
his study compared intravascular ultrasound (IVUS) findings in patients with very late stent
hrombosis (VLST) with either drug-eluting stent (DES) or bare-metal stent (BMS). VLST
as defined as 1 year since stent implantation. Stent malapposition was observed in
4% of DES patients, but in no BMS patients. Disease progression with neointimal
upture within the stent was observed in 44% of DES patients and 100% of BMS
atients. Stent malapposition was unique to DES-related VLST, while disease
rogression with neointimal rupture was more common in BMS patients. These
ndings suggest that different biological mechanisms underlie VLST development
epending upon the stent type.ditorial Comment: Douglass A. Morrison, p. 1943
(continued on page A-22)
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EEART FAILURE1945CHF Limits Exercise Through Both Cardiac and Peripheral Limitationsabio Esposito, Odile Mathieu-Costello, Ralph Shabetai, Peter D. Wagner, Russell S. Richardson
sposito and colleagues performed a series of experiments to identify the role of centrally
imited O2 supply versus compromised peripheral O2 utilization as the etiology for reduced
xercise capacity in patients with congestive heart failure (CHF). O2 transport and
etabolism were compared during maximal cycle exercise, which requires multiple large
uscle groups, to a knee-extensor (KE) exercise, which uses only a single peripheral muscle
roup. The studies were done in patients with CHF and healthy controls during both
ormoxia and hyperoxia (100% O2). For CHF patients, reduced cardiac output resulted in
educed O2 delivery during cycling, while during KE, there was impaired peripheral O2
xtraction from the blood to skeletal muscle.EART RHYTHM DISORDERS1955QTc Prolongation With Standing Helps to Identify Subjects With LQTSami Viskin, Pieter G. Postema, Zahurul A. Bhuiyan, Raphael Rosso, Jonathan M. Kalman,
itendra K. Vohra, Milton E. Guevara-Valdivia, Manlio F. Marquez, Evgeni Kogan, Bernard Belhassen,
ichael Glikson, Boris Strasberg, Charles Antzelevitch, Arthur A. M. Wilde
iskin and colleagues sought to determine if the short-lived sinus tachycardia that occurs
pon standing would expose changes in the QT interval that could identify subjects with long
T syndrome (LQTS). A total of 68 patients with LQTS and 82 controls underwent a
aseline electrocardiogram (ECG) while in the supine position and were then asked to stand
p quickly and then remain still during continuous ECG recording. On average the QT
nterval of controls shortened by 21 ms while the QT interval of LQTS patients increased
y 4 ms. Since the R-R interval shortened more than the QT interval, the QTc increased by
0 ms in the control group and by 89 ms in the LQTS group. Evaluation of the response of
he QT interval to the brief tachycardia induced by standing provides important information
hat aids in the diagnosis of LQTS.
ditorial Comment: Wojciech Zareba, p. 1962(continued on page A-24)
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iARDIAC IMAGING1965New SPECT Camera Can Reduce Scan Time by 80%ali Sharir, Piotr J. Slomka, Sean W. Hayes, Marcelo F. DiCarli, Jack A. Ziffer, William H. Martin,
alia Dickman, Simona Ben-Haim, Daniel S. Berman
new, compact gamma camera system employing a novel design of photon acquisition, and
mage reconstruction has recently been developed. This technology allows reduction of the
est/stress acquisition times from 20/15 min to 4/2 min. Sharir and colleagues performed
equential acquisitions on patients using conventional and high-speed scanners in 238 subjects
t 4 different sites. There was a high degree of correlation for stress and rest scans for total
erfusion defect. Post-stress ejection fraction and end-diastolic volume by the 2 methods were
inearly correlated. The high-speed single-photon emission computed tomography (SPECT)
echnology provides quantitative measures of myocardial perfusion and function comparable to
onventional SPECT at one-seventh the acquisition time.ditorial Comment: Frans J. Th. Wackers, p. 1975ASCULAR DISEASE1979Smoking Linked to Progressive Arterial Stiffeningirofumi Tomiyama, Hideki Hashimoto, Hirofumi Tanaka, Chisa Matsumoto, Mari Odaira,
iko Yamada, Masanobu Yoshida, Kazuki Shiina, Mikio Nagata, Akira Yamashina
o previous prospective study has examined the effect of smoking on the progression of
rterial stiffening. Tomiyama and colleagues reviewed data on more than 2,000 Japanese
ubjects (age 40  8 years), with brachial-ankle pulse wave velocity (baPWV) measured at
aseline and 5 to 6 years later. The annual rate of change of the baPWV was significantly
reater in continuous heavy smokers (11.0 cm/s/year) than in never-smokers (5.5 cm/s/year).
his difference remained significant after adjustments for known cardiovascular risk factors.
moking appears to accelerate the age-associated progression of structural stiffening of the
arge- to middle-sized arteries.EXPEDITED PUBLICATION XPEDITED PUBLICATION1988Quitting Smoking Improves Endothelial Functioneather M. Johnson, Linda K. Gossett, Megan E. Piper, Susan E. Aeschlimann, Claudia E. Korcarz,
imothy B. Baker, Michael C. Fiore, James H. Stein
ohnson and colleagues sought to determine if smoking cessation improves flow-mediated
ilation (FMD) of the brachial artery (BA). The FMD measurements were done as part of a
-year trial on the effects of 5 different smoking cessation pharmacotherapies. FMD was
easured before and 1 year after the target smoking cessation date. After 1 year, 36% of
ubjects successfully quit smoking. FMD increased from 6.2% to 7.2% in those who quit, but
id not change in those who continued to smoke. Smoking cessation leads to prolonged
mprovements in endothelial function.
